HK1045809B - 多環2-氨基噻唑體系在預防或治療肥胖的藥物製備中的用途 - Google Patents
多環2-氨基噻唑體系在預防或治療肥胖的藥物製備中的用途Info
- Publication number
- HK1045809B HK1045809B HK02107056.4A HK02107056A HK1045809B HK 1045809 B HK1045809 B HK 1045809B HK 02107056 A HK02107056 A HK 02107056A HK 1045809 B HK1045809 B HK 1045809B
- Authority
- HK
- Hong Kong
- Prior art keywords
- treatment
- obesity
- polycyclic
- prophylaxis
- medicaments
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Child & Adolescent Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19908537A DE19908537A1 (de) | 1999-02-26 | 1999-02-26 | Verwendung von polycyclischen 2-Amino-Thiazol Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas |
PCT/EP2000/000925 WO2000051602A1 (de) | 1999-02-26 | 2000-02-05 | Verwendung von polycyclischen 2-amino-thiazol systemen zur herstellung von medikamenten zur prophylaxe oder behandlung von obesitas |
Publications (2)
Publication Number | Publication Date |
---|---|
HK1045809A1 HK1045809A1 (en) | 2002-12-13 |
HK1045809B true HK1045809B (zh) | 2005-04-22 |
Family
ID=7899081
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK02107056.4A HK1045809B (zh) | 1999-02-26 | 2002-09-26 | 多環2-氨基噻唑體系在預防或治療肥胖的藥物製備中的用途 |
Country Status (16)
Country | Link |
---|---|
US (1) | US6476059B1 (zh) |
EP (1) | EP1173176B1 (zh) |
JP (1) | JP4728483B2 (zh) |
KR (1) | KR20020002394A (zh) |
CN (1) | CN1161120C (zh) |
AT (1) | ATE267597T1 (zh) |
AU (1) | AU766295B2 (zh) |
BR (1) | BR0008557A (zh) |
CA (1) | CA2362554A1 (zh) |
DE (2) | DE19908537A1 (zh) |
DK (1) | DK1173176T3 (zh) |
ES (1) | ES2218122T3 (zh) |
HK (1) | HK1045809B (zh) |
PT (1) | PT1173176E (zh) |
WO (1) | WO2000051602A1 (zh) |
ZA (1) | ZA200106199B (zh) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19908538A1 (de) * | 1999-02-26 | 2000-08-31 | Aventis Pharma Gmbh | Polycyclische 2-Amino-Thiazol Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen |
EP1816127A1 (en) * | 1999-04-22 | 2007-08-08 | H. Lundbeck A/S | Triazine derivatives for use as selective npy (y5) antagonists |
WO2001064675A1 (en) * | 2000-03-03 | 2001-09-07 | Novartis Ag | Condensed thiazolamines and their use as neuropeptide y5 antagonists |
CA2414623A1 (en) * | 2000-08-01 | 2002-02-07 | University Of Virginia Patent Foundation | Use of selective adenosine a1 receptor agonists, antagonists and allosteric enhancers to manipulate angiogenesis |
CA2471989A1 (en) * | 2002-01-16 | 2003-07-31 | University Of Virginia Patent Foundation | 2-aminothiazole allosteric enhancers of a1 adenosine receptors |
CA2530634A1 (en) * | 2003-06-12 | 2004-12-23 | Menachem Rubinstein | Methods of treating obesity and related disorders using tellurium and selenium compounds |
WO2006013054A1 (en) | 2004-08-05 | 2006-02-09 | F. Hoffmann-La Roche Ag | Substituted n-acyl-2-aminothiazoles |
WO2006080406A1 (ja) * | 2005-01-28 | 2006-08-03 | Taisho Pharmaceutical Co., Ltd. | 三環性化合物 |
CL2009000780A1 (es) | 2008-03-31 | 2010-01-15 | Genentech Inc | Compuestos derivados de heterociclil-pirano-heterociclilo, heterociclil-oxepina-heterociclilo, benzopirano-heterociclilo y benzoxepina-heterociclilo sustituidos; composicion farmaceutica; procedimiento de preparacion de la composicion; kit farmaceutico; y su uso en el tratamiento del cancer, mediado por la inhibicion de pi3k. |
PE20121025A1 (es) | 2009-09-28 | 2012-08-06 | Hoffmann La Roche | Compuestos de benzoxazepina como inhibidores de la p13k |
JP5546636B2 (ja) | 2009-09-28 | 2014-07-09 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | ベンゾキセピンpi3k阻害剤化合物及び使用方法 |
CA2825966A1 (en) | 2011-03-21 | 2012-09-27 | F. Hoffmann-La Roche Ag | Benzoxazepin compounds selective for pi3k p110 delta and methods of use |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3507868A (en) * | 1968-10-21 | 1970-04-21 | Sandoz Ag | Imidazo(2,1-b)thiazoles and thiazolo(3,2-a)pyrimidines |
DE2640358A1 (de) * | 1976-09-08 | 1978-03-16 | Hoechst Ag | Thiazolidinderivate und verfahren zu ihrer herstellung |
JPS5334471A (en) * | 1976-09-10 | 1978-03-31 | Toshiba Corp | Manufacture for semiconductor device |
CA1292226C (en) * | 1986-01-16 | 1991-11-19 | Terumi Hachiya | Indenothiazole derivative and process for preparing the same |
IE68593B1 (en) * | 1989-12-06 | 1996-06-26 | Sanofi Sa | Heterocyclic substituted acylaminothiazoles their preparation and pharmaceutical compositions containing them |
DE19831878C2 (de) * | 1998-07-17 | 2001-05-17 | Aventis Pharma Gmbh | Polycyclische Thiazolidin-2-yliden Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
DE19908538A1 (de) * | 1999-02-26 | 2000-08-31 | Aventis Pharma Gmbh | Polycyclische 2-Amino-Thiazol Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen |
-
1999
- 1999-02-26 DE DE19908537A patent/DE19908537A1/de not_active Withdrawn
-
2000
- 2000-02-05 EP EP00905028A patent/EP1173176B1/de not_active Expired - Lifetime
- 2000-02-05 AU AU26703/00A patent/AU766295B2/en not_active Ceased
- 2000-02-05 CN CNB008042209A patent/CN1161120C/zh not_active Expired - Fee Related
- 2000-02-05 KR KR1020017010840A patent/KR20020002394A/ko not_active Application Discontinuation
- 2000-02-05 WO PCT/EP2000/000925 patent/WO2000051602A1/de not_active Application Discontinuation
- 2000-02-05 BR BR0008557-0A patent/BR0008557A/pt not_active IP Right Cessation
- 2000-02-05 ES ES00905028T patent/ES2218122T3/es not_active Expired - Lifetime
- 2000-02-05 DE DE50006603T patent/DE50006603D1/de not_active Expired - Lifetime
- 2000-02-05 CA CA002362554A patent/CA2362554A1/en not_active Abandoned
- 2000-02-05 AT AT00905028T patent/ATE267597T1/de not_active IP Right Cessation
- 2000-02-05 PT PT00905028T patent/PT1173176E/pt unknown
- 2000-02-05 DK DK00905028T patent/DK1173176T3/da active
- 2000-02-05 JP JP2000602070A patent/JP4728483B2/ja not_active Expired - Fee Related
- 2000-02-10 US US09/501,209 patent/US6476059B1/en not_active Expired - Lifetime
-
2001
- 2001-07-27 ZA ZA200106199A patent/ZA200106199B/en unknown
-
2002
- 2002-09-26 HK HK02107056.4A patent/HK1045809B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU2670300A (en) | 2000-09-21 |
EP1173176B1 (de) | 2004-05-26 |
DE19908537A1 (de) | 2000-08-31 |
US6476059B1 (en) | 2002-11-05 |
ZA200106199B (en) | 2002-03-06 |
HK1045809A1 (en) | 2002-12-13 |
ATE267597T1 (de) | 2004-06-15 |
PT1173176E (pt) | 2004-09-30 |
AU766295B2 (en) | 2003-10-16 |
CN1349404A (zh) | 2002-05-15 |
KR20020002394A (ko) | 2002-01-09 |
JP2002538117A (ja) | 2002-11-12 |
DE50006603D1 (de) | 2004-07-01 |
WO2000051602A1 (de) | 2000-09-08 |
EP1173176A1 (de) | 2002-01-23 |
JP4728483B2 (ja) | 2011-07-20 |
ES2218122T3 (es) | 2004-11-16 |
DK1173176T3 (da) | 2004-09-27 |
BR0008557A (pt) | 2001-12-18 |
CA2362554A1 (en) | 2000-09-08 |
CN1161120C (zh) | 2004-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY137039A (en) | Thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof | |
JO2353B1 (en) | New derivatives of mixed-ring fluoroglycosides and drugs containing these compounds and their use | |
MX2007000505A (es) | Derivados de oxindol sustituidos y medicamentos que contienen los mismos. | |
MY133732A (en) | Sulfonylcarboxamide derivatives, process for their preparation and their use as medicines | |
MXPA03010565A (es) | Derivados de quinolina como ligandos para receptor del neuropeptido y. | |
MXPA03000428A (es) | Derivados de tetrahidro-heterociclo-acepinil-pirimidina. | |
HK1045809A1 (en) | Utilization of polycyclic 2-amino-thiazole systemsin the production of medicaments for prophylaxis or treatment of obesity. | |
MXPA04002825A (es) | Derivados de quinolina como antagonistas de neuropeptido y. | |
AU2003300911A1 (en) | Heterocyclic compounds as ccr5 antagonists | |
WO2001051473A8 (de) | 1,2-diarylbenzimidazole zur behandlung von krankungen die mit einer microglia-aktivierung assoziiert sind | |
GEP20053617B (en) | Bridged Piperazine Derivatives | |
MY133112A (en) | 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use | |
HK1044467A1 (en) | Use of polycyclic thiazole systems for producing medicaments for preventing or treating obesity | |
MY133107A (en) | Use of pyrimidine derivatives for the prophylaxis and therapy of cerebral ischemia | |
IL166057A0 (en) | Urea-substituted and urethane-substituted acylureas methods for the production thereof and their useas medicaments | |
HK1043117A1 (en) | Polycyclic 2-amino-thiazole systems, method for the production thereof and medicament containing said compounds | |
MXPA04001847A (es) | Uso de sistemas de indan-1-ol polisbstituidos para producir drogas utilizadas en la profilaxis o tratamiento de la obesidad. | |
WO2001016096A3 (de) | Verwendung von bissulfonamiden zur herstellung von medikamenten zur prophylaxe oder behandlung von hyperlipidämie | |
HK1042300A1 (en) | Polycyclic thiazole systems and their utilization as anorectics. | |
WO2005079769A3 (en) | Piperazine derivatives for the treatment of endometriosis | |
TW200505892A (en) | Substituted 3-(benzoylureido)thiophene derivatives, processes for preparing them and their use | |
NO20013408L (no) | Anvendelse av 2-substituerte 1,2-benzisotiazol-derivater og 3- substituerte tetrahydropyridopyrimidinon-derivater for profylakseog terapi av cerebral ischemi | |
YU30602A (sh) | Primena 2-amino-3,4-dihidro-hinazolina za proizvodnju leka za lečenje ili profilaksu bolesti koje su prouzrokovane ishemičnim stanjima | |
MXPA04001858A (es) | Uso de derivados de sistemas de indan-1-ol c2-substituidos para producir medicamentos para la profilaxis o el tratamiento de la obesidad. | |
CA2432945A1 (en) | Use of doxylamime succinate and pyridoxine hydrochloride for prophylaxis and treatment of post-surgical vomiting |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20090205 |